Medcomtech, S.A. distributes products in the areas of orthopedic surgery, traumatology, neurosurgery, and anesthesia worldwide.
Fair value with acceptable track record.
Share Price & News
How has Medcomtech's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MED has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: MED underperformed the Spanish Healthcare industry which returned 1.4% over the past year.
Return vs Market: MED exceeded the Spanish Market which returned -22.5% over the past year.
Price Volatility Vs. Market
How volatile is Medcomtech's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall StIf You Had Bought Medcomtech (BME:MED) Stock Five Years Ago, You'd Be Sitting On A 85% Loss, Today
4 months ago | Simply Wall StWe're Not So Sure You Should Rely on Medcomtech's (BME:MED) Statutory Earnings
5 months ago | Simply Wall StWould Medcomtech (BME:MED) Be Better Off With Less Debt?
Is Medcomtech undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate MED's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate MED's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: MED is good value based on its PE Ratio (2.9x) compared to the Healthcare industry average (22x).
PE vs Market: MED is good value based on its PE Ratio (2.9x) compared to the Spanish market (14.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MED's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MED is good value based on its PB Ratio (1.3x) compared to the XE Healthcare industry average (1.8x).
How is Medcomtech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medcomtech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Medcomtech is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Medcomtech competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Medcomtech performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MED has a high level of non-cash earnings.
Growing Profit Margin: MED became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: MED has become profitable over the past 5 years, growing earnings by -31.5% per year.
Accelerating Growth: MED has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MED has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-2%).
Return on Equity
High ROE: MED's Return on Equity (43.4%) is considered outstanding.
How is Medcomtech's financial position?
Financial Position Analysis
Short Term Liabilities: MED's short term assets (€23.3M) exceed its short term liabilities (€16.6M).
Long Term Liabilities: MED's short term assets (€23.3M) exceed its long term liabilities (€6.9M).
Debt to Equity History and Analysis
Debt Level: MED's debt to equity ratio (93.9%) is considered high.
Reducing Debt: MED's debt to equity ratio has increased from 44.6% to 93.9% over the past 5 years.
Debt Coverage: MED's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if MED's interest payments on its debt are well covered by EBIT.
What is Medcomtech's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MED's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MED's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: MED is not paying a notable dividend for the Spanish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MED's dividend in 3 years as they are not forecast to pay a notable one for the Spanish market.
How experienced are the management team and are they aligned to shareholders interests?
Juan Sagales Manas
Mr. Juan Sagales Manas serves as the Chairman of the Board, Chief Executive Officer and President at Medcomtech S.A.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medcomtech, S.A.'s company bio, employee growth, exchange listings and data sources
- Name: Medcomtech, S.A.
- Ticker: MED
- Exchange: BME
- Founded: 2001
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: €13.153m
- Shares outstanding: 12.89m
- Website: https://www.medcomtech.es
Number of Employees
- Medcomtech, S.A.
- Edificio Brasil
- Viladecans Business Park
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MED||BME (Bolsas y Mercados Espanoles)||Yes||Registered Shares||ES||EUR||Mar 2010|
Medcomtech, S.A. distributes products in the areas of orthopedic surgery, traumatology, neurosurgery, and anesthesia worldwide. The company offers orthopedic surgery, trauma, and neurosurgery products for spine, hip-femur-knee, biologics, and upper and lower limbs, as well as biologics and cements. It also provides anesthesia products in the area of airway management. The company was founded in 2001 and is based in Barcelona, Spain.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/27 06:18|
|End of Day Share Price||2020/05/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.